London, January 29: Google DeepMind unveiled a pioneering artificial intelligence tool named AlphaGenome, designed to interpret vast strands of DNA and predict how subtle mutations influence biological processes. The programme can analyse up to a million base pairs at once, allowing scientists to observe how specific genetic changes drive diseases. The technology is expected to usher in a new era of personalised medicine by enabling the creation of synthetic DNA. These synthetic sequences act as a "switch" within a delivery vector, ensuring that a therapeutic gene only activates in target tissues, such as the liver or retina, while remaining inactive elsewhere in the body. DeepMind AI Research SEO KeywordAlphaGenome was trained using both human and mouse genomes to understand how different sequences drive various biological functions.